Reuters -- U.S. drug reviewers identified three major statistical issues in River Plate Biotechnology’s application to market a solution to treat dry eye, documents released on Wednesday said.
Reuters -- U.S. drug reviewers identified three major statistical issues in River Plate Biotechnology’s application to market a solution to treat dry eye, documents released on Wednesday said.
